HbA1c News and Research

RSS

Trinidad and Tobago, Johns Hopkins Medicine celebrate achievements of Diabetes Outreach Program

Members of the Trinidad and Tobago Health Science Initiative’s Diabetes Outreach Program joined the country’s Minister of Health Fuad Khan Tuesday in Port of Spain to celebrate the program’s achievements in fighting diabetes in Trinidad and Tobago.

30 Jan 2014

Copenhagen researchers boost self-efficacy of diabetic patients through motivational health coaching

By means of so-called health coaching, researchers at the University of Copenhagen have helped a large group of diabetics to markedly improve their oral health.

27 Jan 2014

Diabetes research underlines the importance of achieving blood sugar goals

Diabetes research led by the University of Exeter Medical School has underlined the importance of people with diabetes achieving their blood sugar goals, to reduce the risk of complications.

17 Jan 2014

Research findings provide insights into risks associated with isolated mild hyperglycemia

Despite having mild hyperglycemia for approximately 50 years, patients with a mutation in the gene encoding the enzyme glucokinase had a low prevalence of clinically significant vascular complications, findings that provide insights into the risks associated with isolated mild hyperglycemia, according to a study in the January 15 issue of JAMA.

15 Jan 2014

Gastric bypass and cardiovascular disease risk: an interview with Dr. Brethauer, Cleveland Clinic

Gastric bypass surgery is a type of bariatric operation that results in weight loss and stimulates metabolic effects that treat diabetes and other cardiovascular risk factors such as diabetes, high cholesterol, and hypertension.

9 Jan 2014

StemGenex offers stem cell treatment studies to patients diagnosed with diabetes, neurological diseases

According to The American Diabetes Association there are over 25 million people in the US living with diabetes. These patients are suffering from complications such as heart disease, stroke, high blood pressure, blindness, kidney disease, neuropathy and amputation.

8 Jan 2014

EKF Diagnostics to exhibit two POC testing analyzers for diabetes management at Arab Health

EKF, will be exhibiting two newly introduced point-of-care testing analyzers for rapid assessment of diabetes and related conditions.

From EKF Diagnostics 8 Jan 2014

Linagliptin as monotherapy or in combination with metformin reduces blood glucose levels in T2D patients

Boehringer Ingelheim and Eli Lilly and Company today announced new data from a Phase IV study evaluating linagliptin (5 mg) as monotherapy and in combination with metformin (1500 or 2000 mg) in treatment-naive adults with newly diagnosed (<12 months) uncontrolled Type 2 Diabetes.

4 Dec 2013

Scientific poster on EKF's Quo-Test and Quo-Lab POCT HbA1c analyzers to be presented at IDF 2013

EKF, announces the successful assessment of its Quo-Test and Quo-Lab point-of-care HbA1c analyzers within the College of Medicine, Swansea University.

From EKF Diagnostics 4 Dec 2013

Study supports use of EndoBarrier Therapy for patients with type 2 diabetes and obesity

GI Dynamics, Inc. today announced findings from a new meta-analysis which describes the increasingly robust efficacy and safety profile of EndoBarrier Therapy, an endoscopically-delivered device therapy approved for the treatment of type 2 diabetes and obesity.

3 Dec 2013

Study finds few beneficial effects of metformin drug for cardiovascular disease in people without diabetes

Despite high expectations for the commonly used diabetes drug metformin to improve risk factors for heart disease in people without diabetes, few beneficial effects have been found in a randomised trial of patients with established cardiovascular disease, published in The Lancet Diabetes & Endocrinology.

7 Nov 2013

Linagliptin shows efficacy, tolerability in adults with T2D and liver disease

Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.

7 Nov 2013

Kamada announces new data from Glassia Phase I/II study in pediatric patients with type 1 diabetes

Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, today reported preliminary data from the Company's ongoing extension study of a Phase I/II clinical trial with its lead product Glassia® to treat pediatric patients with a recently diagnosed type 1 diabetes (T1D).

31 Oct 2013

People with higher blood sugar levels more likely to have memory problems

Even for people who don't have diabetes or high blood sugar, those with higher blood sugar levels are more likely to have memory problems, according to a new study published in the October 23, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.

24 Oct 2013

EKF publishes new white paper detailing successful evaluation of POCT HbA1c analyzers

EKF, announces publication of a new white paper detailing the successful external evaluation of its Quo-Test and Quo-Lab glycated hemoglobin analyzers.

From EKF Diagnostics 23 Oct 2013

New NPS MedicineWise case study focuses on type 2 diabetes

The latest NPS MedicineWise case study Type 2 diabetes: tailoring ongoing treatment has been launched in a new dynamic online format. The case study focuses on available treatment options for a 75-year-old male with type 2 diabetes and offers continuing professional development points for GPs, pharmacists and nurses.

22 Oct 2013

Novel DiaRem scoring system can predict diabetes remission after gastric bypass surgery

US Scientists have developed a simple scoring system (DiaRem), based on four readily available preoperative patient characteristics, that can predict which candidates for gastric bypass surgery are likely to achieve diabetes remission within 5 years.

13 Sep 2013

Study assesses relationship between BMI and CV events in hypertensive patients with diabetes

Low BMI is a risk factor for CVD in hypertensive patients with diabetes, according to research presented at the ESC Congress today by Dr Takanori Nagahiro from Japan. The findings provide evidence for an obesity paradox in hypertensive patients with glucose intolerance.

3 Sep 2013

Insulin pumps more effective at controlling blood sugar in children with type 1 diabetes

The longest and largest study of the effectiveness of insulin pumps to treat type 1 diabetes in children has shown that the pumps are more effective at controlling blood sugar than insulin injections and cause fewer complications.

20 Aug 2013

Study: Type 2 diabetic patients treated with DPP-4 linagliptin experience reductions in blood glucose levels

Data published in The Lancet showed that elderly people with Type 2 Diabetes (T2D) treated for 24 weeks with the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin, marketed by Boehringer Ingelheim and Eli Lilly and Company, experienced significant reductions in blood glucose levels (HbA1c) compared with those receiving placebo.

17 Aug 2013